Sustained-Release Ruxolitinib: Findings From a Phase 1 Study in Healthy Subjects and a Phase 2 Study in Patients With Myelofibrosis
Hematological Oncology - United Kingdom
doi 10.1002/hon.2544
Full Text
Open PDFAbstract
Available in full text
Date
September 11, 2018
Authors
Publisher
Wiley